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KESAN LIPOPROTEIN KETUMPATAN RENDAH TEROKSIDA OLEH 
THYMOQUINONE DALAM SEL BARAH PAYUDARA MCF-7 
 
ABSTRAK 
 Kanser payudara adalah punca utama kematian di kalangan wanita di seluruh 
dunia dan kajian baru-baru ini mendedahkan bahawa lipoprotein berketumpatan 
rendah teroksida (ox-LDL) menyumbang kepada peningkatan risiko kanser payudara. 
Thymoquinone (TQ) telah dikaji secara meluas dalam patogenesis kanser melalui in 
vivo dan in vitro, tetapi terdapat kekurangan laporan mengenai kawal atur lipid dalam 
sel kanser. Oleh itu, objektif kajian ini adalah untuk menjelaskan kesan ox-LDL 
kepada pertumbuhan sel kanser payudara serta mekanisma metabolisma lipid dan 
pertumbuhan sel di peringkat molekul yang dikawal atur oleh TQ. Kesan toksik TQ 
dianalisis melalui ujian MTS. Sel MCF-7 didedahkan kepada 10 μg/ml ox-LDL, 
diikuti oleh rawatan dengan 20 µM TQ untuk kajian ke atas kebergantungan kepada 
masa. Lokasi dan ekspresi protein sasaran dikaji melalui kaedah immunopendarfluor 
dan pemendapan Western. Ini diikuti oleh analisis qRT-PCR ke atas ekspresi VAMP4 
dan EGLN1. Nilai IC50 untuk tempoh 24, 48 dan 74 jam rawatan TQ adalah masing-
masing 20 µM, 24 µM dan 10 µM. Ox-LDL menyebabkan Bcl-2 berada dalam 
nukleus, manakala NFκB kekal dalam sitoplasma sel selepas rawatan. Ia 
menunjukkan bahawa pengaktifan NFκB telah dihalang oleh ox-LDL. Analisis lanjut 
menunjukkan bahawa ox-LDL menggalakkan proliferasi sel MCF-7 melalui 
peningkatan kawal atur Bcl-2 dan NFκB manakala untuk FASN, ox-LDL telah 
menurunkan ekspresinya. Selepas rawatan dengan TQ selama 72 jam, LDLR dan 
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NFκB menunjukkan pengurangan yang lebih tinggi berbanding dua protein lain yang 
dikaji. Di samping itu, FASN adalah satu-satunya protein yang menunjukkan 
perencatan yang ketara oleh TQ berbanding ekspresinya dalam sel tanpa rawatan 
(nilai-p<0.05). Analisis selanjutnya melalui eksperimen qRT-PCR mendedahkan 
bahawa TQ meningkatkan pengawalaturan ekspresi VAMP4 dengan signifikan 
selepas 72 jam rawatan (nilai-p<0.05) sebagai tindak balas kepada perencatan FASN 
dan Bcl-2. Tahap EGLN1 berkurangan pada 48 jam rawatan TQ tetapi kali ganda 
perubahannya lebih rendah berbanding VAMP4. Secara keseluruhan, kajian ini 
menyediakan pemahaman ke atas mekanisma pertumbuhan sel disebabkan oleh ox-
LDL serta kawal atur TQ di dalam sel yang mengandungi lipid. Fungsi LDLR, FASN 
dan VAMP4 dalam sel yang mengandungi lipid boleh dikaji dengan lebih mendalam 
melalui kaedah pengurangan ekspresi genetik menggunakan teknik siRNA dan TQ 
boleh dikaji melalui terapi gabungan dengan ubat kemoterapi bagi kanser positif ER 
yang telah sedia ada di dalam model sel kultur. Untuk kajian akan datang, adalah 
disarankan untuk menggunakan mikroskop mengimbas sefokus untuk mengkaji 
lokasi sesuatu protein dengan lapisan demi lapisan disaring untuk mendapatkan imej 
pendarfluor tiga dimensi yang jelas disebabkan oleh kesan TQ.  
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EFFECTS OF OXIDIZED LOW-DENSITY LIPOPROTEIN BY 
THYMOQUINONE IN LIPID-LOADED MCF-7 BREAST CANCER CELLS 
 
ABSTRACT 
 Breast cancer is the leading cause of death among women worldwide and 
recent studies revealed that oxidized low-density lipoprotein (ox-LDL) contributed to 
increased risk of breast cancer. To date, thymoquinone (TQ) is widely studied both in 
vivo and in vitro in cancer pathogenesis, but there is lack of reports on its lipid 
regulation in cancer cells. Thus, the objectives of this study were to elucidate the 
effects of ox-LDL on breast cancer cell growth as well as the molecular mechanisms 
of lipid metabolism and cell proliferation regulated by TQ. Cytotoxicity of TQ was 
analyzed using MTS assay. MCF-7 cells were exposed to 10 µg/ml of ox-LDL, 
followed by treatment with 20 µM of TQ for time-dependent study. Localization and 
expression of target proteins were studied through immunofluorescence and Western 
blot methods. This was followed by qRT-PCR analysis on genomic expression of 
VAMP4 and EGLN1. The IC50 value for 24, 48 and 74 hours of TQ treatment was 20 
μM, 24 μM and 10 μM respectively. Ox-LDL caused localization of Bcl-2 in the 
nucleus, whereas NFκB remained in the cytoplasm of cells after treatment. This 
indicated that activation of NFκB was inhibited by ox-LDL. Further analysis showed 
that ox-LDL induced MCF-7 cell proliferation through up-regulation of Bcl-2 and 
NFκB expression, whereas in FASN, ox-LDL reduced its expression. After treatment 
with TQ for 72 hours, LDLR and NFκB showed more reduction in their expression 
compared to the other two proteins studied. In addition, FASN was the only protein 
that indicated significant inhibition by TQ compared to its expression in native cells 
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(p-value < 0.05). Further analysis through qRT-PCR experiments revealed that TQ 
significantly up-regulated VAMP4 expression at 72 hours TQ treatment (p-value < 
0.05) in response to the inhibition of FASN and Bcl-2. EGLN1 level was reduced at 
48 hours TQ treatment but the fold change was lower compared to VAMP4. Taken 
together, this study provides insight into molecular mechanism of ox-LDL-induced 
cell growth as well as regulation of TQ in lipid-loaded cells. The roles of LDLR, 
FASN and VAMP4 in lipid-loaded cells could be further studied through their gene 
knockdown using siRNA technique and TQ may also be examined in combined 
therapy with the existing ER-positive chemotherapeutic agent in cell culture model. 
For future studies, it is recommended to use confocal scanning microscope to study 
the localization of a protein by scanning many thin sections through a sample to 
obtain a clear three-dimensional fluorescent image due to TQ effect.   
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CHAPTER 1 
       INTRODUCTION 
 
1.1 Cancer 
Cancer is among the leading causes of death worldwide. According to the 
World Health Organization (WHO), approximately 8.2 million deaths were due to 
cancer and 14.1 million new cancer cases were reported in 2012 across the world. It 
is also a major health problem in Malaysia, accounting for 11.28 % of total death in 
2007 and the third cause of death among Malaysian population (Omar and Ibrahim, 
2011). Cancer is a group of diseases characterized by rapid and uncontrolled 
proliferation of abnormal cells. It can start almost anywhere in the human body due 
to the genetic changes or external factors such as chemicals and radiation (National 
Cancer Institute, 2015).  
There are more than 100 types of cancers (National Cancer Institute, 2015). 
Carcinomas are cancers that arise in the epithelium and it can be divided into 
adenocarcinomas and squamous cell carcinomas. Adenocarcinomas refer to cancers 
that develop in an organ or a gland, while squamous cell carcinomas are cancers that 
originate in the skin. Melanomas also develop in the skin, usually in the pigment 
cells called melanocytes. Sarcomas are cancers of the supporting tissues of the body 
such as blood vessels, bone and muscle. Gliomas are cancers of the nerve tissue. 
Cancers of the blood are known as leukemias while cancers of the lymph glands are 
known as lymphomas (Cancer Research UK, 2014).  
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Most cancers form a lump called a tumour, but not all lumps are cancer. 
Tumours can be benign tumours which do not invade other tissues, whereas 
malignant tumours have the ability to invade and metastasize from their primary site 
to other parts of the body through bloodstream or lymph vessels (American Cancer 
Society, 2015). Statistics from the International Agency for Research on Cancer 
(IARC) in 2012 showed that the four leading types of cancer in the world are lung, 
breast, colorectum and prostate cancer (Figure 1.1). 
 
1.2 The epidemiology of breast cancer  
In Malaysia, breast cancer is the most frequent type of cancer reported in 
2007 (Omar and Ibrahim, 2011) and the second most frequent cancer worldwide in 
2012 (IARC, 2012). As shown in Table 1.1, breast cancer constitutes 18.1 % of all 
cancer cases reported among Malaysian population in 2007, with high incidence 
among women aged 35 years old and above. Among the different ethnic groups in 
Malaysia, Chinese has the highest incidence rate (38.1 per 100,000) followed by the 
Indians (33.7 per 100,000) and Malays (25.4 per 100,000) for age-standardized rate 
(ASR) in 2007. Out of 3,242 female breast cancer cases diagnosed in 2007, 42 % of 
them were at stage 3 and 4 (Omar and Ibrahim, 2011). Malay women have a poorer 
survival compared to the other two main ethnics. Even though the cause is unclear, it 
was thought that pharmacogenomics, lifestyle factors (weight-gain, diet, and 
exercise) and psychosocial factors (acceptance of second or third line chemotherapy) 
may be responsible for the difference in survival. Nulliparity, family history, not 
breastfeeding and use of oral contraceptives are among the factors that are believed 
to increase risk of breast cancer among Malaysian women (Yip et al., 2014). 
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Source: IARC (2012) 
Figure 1.1: Estimated cancer incidence and mortality worldwide in 2012 among men 
and women in all age groups.  
 
 
Table 1.1: The ten leading cancers among the Malaysian population in 2007.  
Type of cancer                      Percentage (%) 
Breast                             18.1 
Colorectal                             12.3 
Trachea, Bronchus, Lung                             10.2 
Nasopharynx                               5.2 
Cervix uteri                               4.6 
Lymphoma                               4.3 
Leukaemia                               4.1 
Ovary                               3.6 
Stomach                               3.5 
Liver                               3.3 
Source: Omar and Ibrahim (2011) 
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1.3 Breast cancer subtypes 
 Breast cancer can be classified into different categories based on its 
histopathological type, stage of the tumour, grade of the tumour and expression of 
hormone receptors. Majority of breast cancers are derived from the epithelium lining 
the ducts or lobules and are classified as mammary ductal carcinoma. Carcinoma in 
situ (CIS) is proliferation of cancer cells within the epithelial tissue without invasion 
of the surrounding tissue, whereas invasive carcinoma invades the surrounding tissue 
(Tripathi et al., 2013).  
 The Tumour-Nodes-Metastasis (TNM) is one of the most widely used cancer 
staging systems (WHO, 2015, Edge and Compton, 2010). The system is based on 
three important criteria which include the primary tumour size (T), the absence or 
presence and extent of regional lymph node metastasis (N) as well as the absence or 
presence of distant metastases (M). There are five stages of breast cancer (0, I, II, III, 
and IV) with stage 0 being in situ, stage I being the early stage invasive cancer, and 
stage IV being the most advanced cancer (WHO, 2015, Edge and Compton, 2010, 
Tavassoli and Devilee, 2003). 
 In addition, three histological grades I, II, and III (also known as Scarff 
Bloom-Richardson grade, Nottingham grade, or Elston-Ellis grade) are used to assess 
the degree of tumour differentiation. It is based on the tubule formation, nuclear 
pleomorphism or how closely they resemble normal breast cells and mitotic rate 
(Edge et al., 2010, Dixon, 2013,). Grade I (well differentiated) cancers have 
relatively normal-looking cells that do not appear to be growing rapidly and are 
arranged in small tubules, whereas grade II (moderately differentiated) cancers have 
moderate features. Grade III (poorly differentiated) cancers, which is the highest 
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grade, are lack of normal features and tend to grow more rapidly and aggressively 
(WHO, 2015). 
 Estrogen and progesterone are the hormones that often fuel the growth of 
breast cancer cells. Cancer cells may have one, both or neither of these receptors. 
Breast cancers that have estrogen receptors are often referred to as ER-
positive cancers, while those containing progesterone receptors are known as PR-
positive cancers. Both ER-positive and PR-positive cancers are also classified as 
hormone receptor-positive cancer. They are more common in women after 
menopause. In addition, tumours with increased levels of HER2/neu gene are referred 
to as HER2-positive. This type of cancer often has high number of copies of 
the HER2/neu gene, resulting in greater than normal amounts of the growth-
promoting protein. Breast cancer cells which do not have estrogen or progesterone 
receptors and do not have too much HER2 expression are called triple-negative. This 
cancer is more common in younger women and among African-American or 
Hispanic/Latina women. Triple-negative breast cancers tend to grow and spread more 
quickly than other types of breast cancer (American Cancer Society, 2015). 
In Malaysia, out of 94 cases of invasive breast ductal carcinoma studied 
between 2006 and 2010, 53.2 % was ER-positive while 24.5 % was HER2-positive 
breast cancer.  Triple negative breast cancer constituted of 22.3 % cases (Ch'ng et al., 
2012). Another study on breast cancer cases in Sarawak also found that ER-positive 
breast cancer had the highest percentage (57 %), followed by triple negative breast 
cancer (29 %), and HER2-positive breast cancer (23 %) (Devi et al., 2012).  
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1.4 Breast cancer risk factors 
Breast cancer is 100 times more common among women than men (American 
Cancer Society, 2015). According to Dahlui et al. (2011), a woman in Malaysia had a 
1 in 20 chance of developing breast cancer in her lifetime. The risk increases as a 
person gets older. About 1 out of 8 invasive breast cancers are found in women at age 
below 45 whereas in women age 55 or older, 2 of 3 invasive breast cancers are found 
(American Cancer Society, 2015).  
Besides gender and age, hormonal factors are likewise implicated. Post-
menopausal women with highest levels of estrogen and testosterone were found to 
have 2-3 times the risk compared to women with the lowest levels (Key et al., 2002). 
Early menarche, nulliparity or first birth after the age of 35 and late menopause may 
increase the risk of breast cancer. Combined hormonal replacement therapy for 
menopausal symptoms increases the risk of breast cancer especially after prolonged 
use (McPherson et al., 2000, Chlebowski et al., 2003). On the other hand, continuous 
breastfeeding up to one and a half or two years may lower the risk, possibly because 
breastfeeding reduces a woman's total number of lifetime menstrual cycles, which is 
similar to the effects of starting menstrual periods at a later age or going through 
early menopause (American Cancer Society, 2015).  
Moreover, genetic predisposition is estimated to contribute to 5-10 % of all 
breast cancer cases (Palma et al., 2006). Susceptibility to breast cancer is generally 
inherited as an autosomal dominant with limited penetrance. Inherited mutations in 
BRCA1 and BRCA2 increase the risk of breast cancer in addition to ovarian cancers 
(McPherson et al., 2000). The BRCA1 and BRCA2 are genes that code for BRCA1 
and BRCA2 tumour suppressor proteins. They are located on the long arms of 
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chromosomes 17 and 13 respectively, functioning to repair damaged dsDNA and 
mutation or alteration in either of these genes can lead to cancer (Foulkes and Shuen, 
2013). Meta-analysis shows that breast cancer risks for mutation carriers are 
approximately 57 % for BRCA1 and approximately 49 % for BRCA2 (Chen and 
Parmigiani, 2007). Other high penetrance alleles identified as part of inherited breast 
cancer syndromes include TP53, PTEN, STK11, CDH1 mutations (Mavaddat et al., 
2010). 
High consumption of meat, dairy products, fat and alcohol were reported to 
increase the risk, whereas healthy diet with high amount of fibre, fruits, vegetables, 
and anti-oxidants may lower the risk of breast cancer. Other well-known risk factors 
are race and ethnicity, a first degree-relative with breast cancer, overweight and 
obesity (especially postmenopausal obesity), oral contraceptives, exposure to tobacco 
products, alcohol intake and radiation (McPherson et al., 2000, Kushi et al., 2012, 
Assi et al., 2013). Before menopause, being overweight or obese modestly decreases 
breast cancer risk, whereas after menopause, being overweight or obese increases 
breast cancer risk (Reeves et al., 2007, Nelson et al., 2012). Barnard et al. (2015) 
conducted a review on current knowledge about the associations between established 
breast cancer risk factors and risk of specific tumour subtypes. Summary of risk 
factor with regard to breast cancer subtype (Luminal A, Luminal B, HER-2 
overexpressing, and triple negative) are shown in Table 1.2.  
 
1.5       Treatment for breast cancer 
There are several treatment options for women diagnosed with breast cancer 
which include surgery, radiation therapy, chemotherapy, hormonal therapy and 
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Table 1.2: Summary of breast cancer risk factor according to subtype. 
Risk factor 
Luminal 
A 
Luminal 
B 
HER2-
overexpressing 
Triple 
negative 
Younger age at menarche + + + unk + + + 
Greater parity − − − unk unk + + 
Older age at first birth + + unk unk unk 
Breastfeeding − − − − unk − − − 
Older age at menopause + + unk unk + 
Greater BMI (premenopausal) − unk unk + 
Greater BMI (postmenopausal) unk unk unk unk 
Family history + + + + + + + + + + 
Alcohol use + unk + unk 
Use of oral contraceptives − unk unk + 
Menopausal hormonal therapy 
use + + unk unk unk 
Source: Barnard et al. (2015) 
 
+++: indicates consistent evidence of a positive association between the risk factor 
and the subtype. 
 
− − −: indicates consistent evidence of a negative association between the risk factor 
and the subtype. 
 
++: indicates a probable positive association between the risk factor and the subtype. 
 
− −: indicates a probable negative association between the risk factor and the 
subtype. 
 
+: indicates a possible positive association between the risk factor and the subtype. 
 
−: indicates a possible negative association between the risk factor and the subtype. 
 
unk: indicates insufficient or inconsistent evidence. 
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targeted therapies. The most appropriate treatment depends on stage and type of 
breast cancer, characteristics of the cancer cells, menopausal status, and the patient’s 
state of health (Peepliwal and Tandale, 2013). There are two types of breast cancer 
surgery which include breast-conserving surgery and mastectomy (American Cancer 
Society, 2015). Radiation therapy is often used after breast-conserving surgery to 
lower the chance of cancer recurrence by destroying residual breast cancer or 
shrinking the tumour before surgery by damaging the double strand DNA of tumour 
cells via radiation. Chemotherapy involves treatment with cancer killing drugs which 
are generally given by injection into a vein to reduce the chance of cancer recurrence 
after surgery or to shrink the tumour before the surgery. In most cases, especially 
adjuvant and neoadjuvant treatment, chemotherapy is most effective when 
combinations of more than one drug are used and the combinations are based upon 
size of tumour, lymph node metastasis, and presence of ER receptor and HER2 
receptor (Peepliwal and Tandale, 2013, Tripathi et al., 2013).  
Hormone therapy is beneficial for hormone receptor-positive breast cancer 
through lowering estrogen levels or inhibiting estrogen from acting on the breast 
cancer. Tamoxifen is among the most common drugs used to block estrogen 
receptors in breast cancer cells and it is often given to patients with early localized 
breast cancer that can be removed by surgery and those with metastatic breast cancer 
(American Cancer Society, 2015). Targeted therapy uses drugs or other substances to 
attack specific cancer cells without harming normal cells. Monoclonal antibodies, 
tyrosine kinase inhibitors, and cyclin-dependent kinase inhibitors are types of 
targeted therapies used in the treatment of breast cancer (National Cancer Institute, 
2015).  
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1.6 Lipid metabolism and cancer  
 Lipid is a diverse group of hydrophobic molecules. It can be obtained either 
from dietary sources or from carbohydrate-derived fatty acids synthesized in the liver 
or in adipocytes. Fatty acids are molecules with long hydrocarbon chains topped with 
a carboxyl group which can be used to generate many types of lipids including 
triacylglycerides, sterols, sphingolipids, phosphoinositides and eicosanoids (Baenke 
et al., 2013). Cholesterol is a type of animal sterols which is essential for structural 
component of animal cell membranes in maintaining membrane integrity and fluidity 
(Hu et al., 2010). The formation of long chain fatty acids is catalyzed by fatty acid 
synthase (FASN) through condensation of acetyl-CoA and malonyl-CoA to produce 
palmitate (Rossi et al., 2003). In normal cells, FASN expression and activity are 
usually low and it is strictly regulated by hormones, diet and growth factors, except 
for liver and adipose tissue (Menendez and Lupu, 2007). In contrast, fatty acids in the 
rapidly proliferating cancer cells can be synthesized de novo to sustain the high 
demand of lipids required for formation of new cell membrane and energy 
production (Menendez and Lupu, 2007, Flavin et al., 2010, Santos and Schulze, 
2012). As such, FASN is often present at high levels in many human cancer cells 
(Kuhajda, 2006).  
 Apart from that, lipids also play important roles as signalling molecules in 
cancer. Examples of lipid-derived signalling molecules include phosphoinositides, 
lysophosphatidic acid (LPA), phosphatidic acid (PA), diacylglycerides (DAG), 
ceramide and sphingosine. Phosphoinositides, LPA, PA, and DAG are important 
second messengers, whereas ceramide and sphingosine are generated in response to 
pro-apoptotic signals such as chemotherapy and UV radiation (Baenke et al., 2013). 
It was reported that the LPA could promote cancer cell proliferation, migration and 
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survival through binding to G-protein-coupled receptors (Mills and Moolenaar, 
2003). In response to innate immunity and inflammation, the cytokine signaling 
pathways induces phospholipases (A2, C, and D), sphingomyelinases and the 
enzymes that regulate cholesterol metabolism (McLaren et al., 2011). According to 
Huang and Freter (2015), most of the mitogenic signaling in mammalian cells is 
carried out by growth factors which regulates cell growth and proliferation as well as 
involves in the activation of many lipid metabolism-related enzymes. 
 Furthermore, cholesterol is the source for biosynthesis of steroid hormones 
such as testosterone, estradiol, progesterone, cortisol/corticosterone and aldosterone 
(Hu et al., 2010). One of the mechanisms by which steroid producing cells acquire 
cholesterol is from plasma low-density lipoprotein (LDL) or other apolipoprotein B- 
(apoB) or apoE-containing lipoproteins through the LDL receptor-mediated 
endocytic pathway (Goldstein and Brown, 2009). Another important derivatives of 
cholesterol are bile salts and vitamin D. Formation of bile salts in the liver is the 
main route for removal of cholesterol circulating in the blood (Papachristodoulou et 
al., 2014), while vitamin D plays a crucial role in the control of calcium and 
phosphorus metabolism (Berg et al., 2002). Numerous studies have suggested that 
high dietary fat intake promotes the growth of colorectal, liver, breast, pancreatic, 
gastrointestinal and prostate cancers (Fleshner et al., 2004, Kwan et al., 2015). 
Reactivation of lipid biosynthesis in cancer cells could lead to enhanced membrane 
lipid saturation, which potentially increases cancer cells resistance to oxidative stress 
and cell death induced by chemotherapeutic agents. It was also reported that tumour-
associated fatty acid synthesis could alter the mobility of membrane components and 
therefore affects the uptake of common chemotherapeutics into the cells (Rysman et 
al., 2010).  
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 In human, excess lipids are stored in lipid droplets in the form of 
triacylglycerides and cholesteryl esters (Beloribi-Djefaflia et al., 2016). Lipid 
droplets are essential for storage of metabolic energy and also provide reservoirs of 
lipids for membrane synthesis (Thiam et al., 2013). In mammary gland, the formation 
of milk globules begins with the formation of ADRP- and TIP47-containing lipid 
droplets in the endoplasmic reticulum. They increase in size through fusion between 
lipid droplets, which is catalysed by the soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor (SNARE) protein domain including SNAP23, syntaxin-5 
and vesicle-associated membrane protein 4 (VAMP4) (Olofsson et al., 2009). In 
addition, knockdown of the genes for SNAP23, syntaxin-5 or VAMP4 in heart 
muscle cells showed reduction in the rate of fusion and the size of the lipid droplets, 
suggesting that the SNARE system is important in lipid droplet fusion (Bostrom et 
al., 2007). Fatty acids mobilized from lipid stores can be degraded in the 
mitochondria through β-oxidation to provide energy when required by cells (Santos 
and Schulze, 2012). Previous studies have reported that diverting fatty acids to 
storage and reducing fatty acid release from storage can control proliferation of 
cancer cells (Currie et al.,2013). Although the exact role of lipid droplets in 
promoting survival of cancer cell remains unclear, it has been suggested that lipid 
droplets could be beneficial during the state of low oxygen availability. After re-
oxygenation, they could be used as a readily available source of energy to sustain 
cancer cells growth (Santos and Schulze, 2012). In other words, previous studies 
demonstrated that both FASN and VAMP4 are the important regulators of cellular 
fatty acid metabolism which can promote cancer cell survival.  
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1.7 Hypoxia in cancer 
 Solid tumours require the right amount of nutrients and oxygen to sustain 
their metabolic needs. Many tumours proliferate very quickly that they exceed their 
own vascular supply, resulting in low oxygen availability or hypoxia. Hypoxia can 
increase cellular reactive oxygen species (ROS) and cause endoplasmic reticulum 
stress (Ackerman and Simon, 2014). This leads to an adaptive response that is 
transcriptionally regulated by the hypoxia-inducible factors (HIF) (Ameln et al., 
2011). Prolyl hydroxylase domain-containing protein 2 (PHD2) is an enzyme 
encoded by the EGLN1 gene (Semenza, 2014) and it is a direct HIF target gene 
(Metzen et al., 2005). HIF activation causes a metabolic switch to anaerobic energy 
production through expression of the glucose transporter 1 (GLUT1) and several 
glycolytic enzymes (Denko, 2008). HIF also prevents the entry of pyruvate into the 
tricarboxylic acid cycle (TCA) cycle by inducing the expression of pyruvate 
dehydrogenase kinase 1.  
 In addition, it has been suggested that PHD2 has the potential as a target for 
monitoring cancer progression and that inactivation of PHD2 could eventually lead to 
overexpression of FASN in hypoxic cancerous cells. This is because during hypoxia, 
HIF-1α does not undergo proteosomal degradation and translocates into the nucleus 
whereby it targets the glycolytic pathway and fatty acid synthesis to fulfill the 
requirement of energy (Singh et al., 2016). Besides, it has been reported that hypoxia 
can activate NFκB activity which is mediated through elevated expression of IκB 
kinases, resulting in increased levels of proinflammatory cytokines. In vitro studies 
on HeLa cells also showed that prolyl hydroxylases (PHDs) suppressed NFκB 
expression and hypoxia increases activity of cellular IKKβ, a critical regulator of 
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NFκB (Cummins et al., 2006). Based on these reports, it is clear that PHD2, FASN 
and NFκB are among the key regulators in cancer cells during hypoxia which 
potentially contribute towards cancer cells survival. Due to its role as a lipid 
metabolic gene and it is important for cellular transformation (Hirsch et al., 2010), 
this study aimed to analyse the link between EGLN1 gene and other lipid metabolism 
genes particularly in breast cancer cells.  
 
1.8 Oxidized low-density lipoprotein (ox-LDL)  
 A lipoprotein particle is a complex of lipids and proteins. Lipids are naturally 
water-insoluble and they are transported in the form of lipid/protein complexes. The 
five major groups of lipoproteins are high-density lipoprotein (HDL), low-density 
lipoprotein (LDL), very low-density lipoprotein (VLDL), intermediate-density 
lipoproteins (IDL), and chylomicrons. The main difference between these lipoprotein 
types are their size, density and protein composition (Jain et al., 2013). Description 
and properties of the different types of lipoproteins are summarized in Table 1.3. 
This study will focus on one of the lipoproteins, LDL, which functions mainly to 
transport cholesterol from liver to other parts of the body.  The core of an LDL 
particle is hydrophobic and consists of esterified cholesterol and triacylglycerol, 
while its outer surface layer of phospholipids is surrounded by a single apo B-100 
protein (Harisa & Alanazi, 2013). Uptake of cholesterol by a cell occurs through 
receptor-mediated endocytosis whereby LDL will bind to LDL receptor (LDLR) and 
form a complex which will be internalized into the cells. LDL dissociates from the 
receptor when the pH drops. The receptor is then recycled to the surface of the cell,  
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Table 1.3: Subtypes of lipoproteins and their properties. 
Source: Jain et al., (2013)  
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while LDL is transferred into the lysosomes for degradation to monomers and 
released into the cytoplasm (Harisa & Alanazi, 2013).   
Production of LDLR is subject to feedback regulation. When cells accumulate 
excess cholesterol, they reduce their receptors whereas when cells are deprived of 
cholesterol, more LDLR is being synthesized. This mechanism of feedback 
regulation of LDLR synthesis was discovered by Goldstein and Brown (1975), who 
studied the LDLR activity in cultured human fibroblasts. It was also reported that 
LDLR makes one round trip into and out of the cell every 10 minutes for a total of 
several hundred trips within its 20 hours of lifespan (Brown et al., 1983). Mechanism 
of LDL uptake through receptor-mediated endocytosis is illustrated in Figure 1.2. 
LDLR is regulated by a pair of sterol-regulated membrane-bound transcription 
factors called SREBPs. It is down-regulated when LDL concentrations are high, and 
fewer receptors appear on the cell surface. When the complex of LDLR and LDL are 
endocytosed, the receptors are recycled back to the cell surface and LDL is 
hydrolysed in lysosomes to release cholesterol, cholesterol esters, phospholipids, and 
amino acids (Papachristodoulou et al., 2014). 
LDL is often linked to atherosclerosis and the main target of therapy for the 
prevention of coronary heart disease (Carmena et al., 2004). It is susceptible to 
oxidative modification (Levitan et al., 2010) and oxidation of LDL is assumed to 
occur in two main stages (Yoshida and Kisugi, 2010). During the initial stages of 
LDL oxidation in vitro, oxidative modifications of LDL result in little change in 
apolipoprotein B100 and such modified LDL is called minimally oxidized LDL 
(Yoshida and Kisugi, 2010).  In the second stage, LDL is further oxidized along with 
modification in the protein portion of LDL, resulting in loss of recognition by the 
LDL receptor and a shift to recognition by the scavenger receptors. This can give rise  
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Figure 1.2: Mechanism of LDL uptake through receptor-mediated endocytosis. 
Adapted from 
http://www.unifr.ch/biology/assets/files/schneiter/lectures/voet_chap_20_new.pdf 
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to foam cells and causes ox-LDL to be more atherogenic than native LDL (Steinberg, 
1997). Levitan et al. (2010) summarized the various bioactive compounds generated 
from LDL oxidation which include phospholipid products, sphingolipid products, 
free fatty acids, oxysterols, cholesteryl ester products, hydroxynonenal and 
malondialdehyde besides modification in functional groups of the Apo-B.  
Apart from its atherogenic property, recent studies also reported that ox-LDL 
stimulated the proliferation of prostate cancer cells (Wan et al., 2015) and human 
mammary epithelial cells MCF-10A (Khaidakov and Mehta, 2012). Delimaris et al. 
(2007) found increased ox-LDL serum levels in stage I and II breast cancer patients, 
and they suggested that serum ox-LDL levels predict an increased risk of breast 
cancer. In contrast, study by Zabirnyk et al. (2010) had demonstrated that ox-LDL 
can initiate cell death of various cancer cell lines including HT29, HeLa, OVCAR3, 
OVCAR5, MCF7, A549 and PC3. However, the cytotoxicity of ox-LDL on these 
cancer cell lines was dose-dependent. Many studies have reported on overexpression 
of LDLR in various types of cancer including adrenal adenoma, colon, pancreatic, 
lung, brain, and prostate cancer (Chen and Hughes-Fulford, 2001). In human breast 
carcinoma cells, studies also showed that treatment with LDL cholesterol or 
overexpression of LDLR could induce tumour cell proliferation (Liu et al., 2013). 
 
1.9 Thymoquinone and its anti-cancer effects 
 Nigella sativa is an annual flowering plant of the Ranunculaceae family that 
is abundant in countries bordering the Mediterranean Sea, Pakistan and India 
(Bassim Atta, 2003). Other common names for Nigella sativa include Black Cumin, 
Fennel Flower, and Habbatus Sauda. It has been used in traditional medicine for 
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treatment of various diseases such as asthma, hypertension, diabetes, inflammation, 
cough, bronchitis, headache, eczema, fever, dizziness, and influenza (Ali and 
Blunden, 2003, Entok et al., 2014). In fact, Prophet Muhammad (PBUH) once stated 
that this plant has the source of healing for every disease except death. The black 
seeds of the plant are the most extensively studied since 1880. The chemical 
composition of the seeds include fixed oil (32 - 40 %), volatile oil (0.4 – 0.45 %), 
proteins (16 – 19.9 %), minerals (1.79 – 3.74 %), alkaloids, coumarins and saponins 
(Hussein El-Tahir and Bakeet, 2006). The volatile oil of black seeds contains a 
bioactive constituent called thymoquinone (TQ). 
 The chemical structure of TQ is 2-isopropyl-5-methyl-benzoquinon 
(AbuKhader, 2013). Studies on TQ revealed that the compound is capable to induce 
cell death of several human cancer cell lines derived from lung, colon, liver, 
melanoma, and breast tumours (Attoub et al., 2013). In addition, TQ was also found 
to be cytotoxic to squamous carcinoma cells (Chu et al., 2014), ovarian 
adenocarcinoma (Shoieb et al., 2003), human pancreatic adenocarcinoma and uterine 
sarcoma (Worthen et al., 1998), as well as colorectal cancer (Hala Gali-Muhtasib, 
2004). In HCT-116 human colon cancer cells, the pro-apoptotic effects of TQ are 
dependent on p53 (Hala Gali-Muhtasib, 2004), whereas in myeloblastic leukemia 
HL-60 cells, induction of apoptosis by TQ occurs through the activation of caspase 3, 
8, and 9 (El-Mahdy et al., 2005). Reports have shown that TQ treatment of HCT-116 
cells demonstrated a marked increase in p53 and p21 protein levels and a significant 
inhibition of anti-apoptotic protein Bcl-2 (Hala Gali-Muhtasib, 2004).  
 Regulation of apoptosis by the Bcl-2 family of proteins can be characterized 
into pro-apoptotic and anti-apoptotic members. The pro-apoptotic proteins are such 
as Bax and Bak, whereas the anti-apoptotic proteins include Bcl-2 and Bcl-XL 
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(Portier and Taglialatela, 2006). Previous studies have shown that Bcl-2 is among the 
genes that are regulated by a transcription factor, nuclear factor-kappa B (NFκB) 
besides Bcl-XL, cIAP, suvivin, TRAF, COX-2, MMP-9 and iNOS (Luqman and 
Pezzuto, 2010). It was reported that activation of NFκB is common in carcinomas, 
which are mainly driven by inflammatory cytokines surrounding the tumour 
microenvironment (DiDonato et al., 2012). NFκB plays important roles in 
inflammation, immunity, cell proliferation and apoptosis. It is involved in cellular 
responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, ox-
LDL and microbial antigens (Luqman and Pezzuto, 2010). To date, numerous studies 
and clinical trials on TQ have been conducted to measure its safety, tolerability and 
toxicity at higher doses. Some researchers also proposed the use of combination of 
TQ with other chemotherapeutic agents such as doxorubicin, as well as TQ-loaded 
nanoparticles for treatment of cancer.   
 
1.10 Problem statement 
 Breast cancer is the most common type of cancer in women and it is a major 
life threatening illness in the world. Numerous anti-cancer modalities have been 
developed and chemotherapy is one of the important treatments for breast cancer. 
Nevertheless, drug resistance is a major challenge in breast cancer chemotherapy and 
frequently accounts for the failure of the treatment.  Recurrence of breast cancer was 
reported in almost 30 % of all patients with early stage of metastatic breast cancer 
(Chang, 2012). On top of that, elevated levels of serum lipid was detected in stage I 
and II of breast cancer patients (Delimaris et al., 2007), thus suggesting its role as an 
important factor that leads to the breast cancer development in these patients. There 
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is limited information on the exact molecular mechanism which relates ox-LDL to 
cancer, therefore it requires further investigation by studying the potential of loading 
breast cancer cells with ox-LDL. This will provide insight into the mechanism by 
which lipid metabolism is regulated in cancer cells. In addition, TQ is widely known 
for its anti-cancer properties and many other medicinal benefits, yet there is lack of 
knowledge on its regulation particularly in lipid-loaded breast cancer cells. Further 
understanding on the targeting sites of TQ may offer therapeutic strategy for cancer 
treatment, since there is increasing evidence that lipids are associated with cancer 
progression. There is a need to discover the molecular mechanism and potential of 
new drugs, which could be used to complement the existing chemotherapeutic 
treatment and overcome the complication of drug-resistance among breast cancer 
patients.  
 
1.11 Objectives of study 
 This study sought to elucidate the effects of ox-LDL on breast cancer cell 
growth and the molecular mechanisms of TQ regulation in lipid-accumulated MCF-7 
cells. To accomplish this goal, the following specific objectives were developed: 
1. To determine the optimum concentration of TQ for treatment on MCF-7 cell line 
based on its half maximal inhibitory concentration (IC50) value.  
2. To assess the roles of ox-LDL in breast cancer cells based on comparison between 
native MCF-7 cells and lipid-loaded MCF-7 cells. 
3. To compare the effects of TQ on localization and expression of the proteins 
involved in lipid metabolism and cell proliferation using proteomic analysis. 
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4. To study the roles of TQ in regulating lipid metabolism and cancer specific genes 
via qRT-PCR method. 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Cell culture 
The human mammary breast cancer epithelial cell line, MCF-7, was obtained 
from American Type Culture Collection (ATCC). The adherent cell line was cultured 
in RPMI-1640 medium with L-glutamine (ATCC, USA), supplemented with 10 % 
heat-inactivated fetal bovine serum (JR Scientific Inc., USA) and 1 % antibiotics 
(10,000 U/ml of penicilin, 10,000 µg/ml of streptomycin) (Gibco, USA). The MCF-7 
cells were seeded in 25 cm
2
 culture flasks (Corning, USA) containing 5 ml complete 
growth medium. All culture flasks were incubated in 37 °C humidified incubator 
(Thermo Fisher Scientific, USA) with 5 % carbon dioxide. Medium renewal was 
done 2 to 3 times per week. 
 
2.2 Subculturing cells 
 The MCF-7 cells were subcultured when they reached 80 - 90 % confluent. 
Medium was removed from the flasks and the cell layer was rinsed twice with 
phosphate buffered saline (PBS) to remove all traces of serum or trypsin inhibitor. 
Then, 3 ml of 0.05 % trypsin-EDTA solution (Gibco, USA) was added to detach the 
cells and culture flasks were incubated in a humidified CO2 incubator for 10 minutes. 
About 4 ml of culture medium was added into the flasks to stop trypsin-EDTA 
reaction on the cells. The detached MCF-7 cells were transferred into centrifuge 
tubes and centrifuged at 125 x g for 7 minutes. After the supernatant was removed, 
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cell pellet was re-suspended with 1 ml fresh culture medium and approximately 
7x10
4
 cells were seeded each new culture flask. The cells were incubated in 37 °C 
incubator.  
 
2.3 Cryopreservation of cell line 
 Cryopreservation was done to preserve cell stock of MCF-7 cell line. After 
cells were collected and pelleted by centrifugation at125 x g for 7 minutes, the cell 
pellet was re-suspended in 1 ml fresh growth medium. Dimethyl sulfoxide (DMSO) 
was used as a cryoprotective agent to prevent formation of ice crystals and 
fragmentation of the cell membrane (Langdon, 2003). DMSO was added to the cell 
suspension at a final concentration of 10 % (Corsini, 2004). Finally, the cell stock 
was transferred into cryotubes and stored at -80 °C. 
 
2.4 Determination of cell number  
 To count the total cell number, medium was first aspirated and transferred 
into 15 ml centrifuge tube. Culture flasks were rinsed with 4 ml phosphate-buffered 
saline (PBS) and 3 ml of 0.05 % Trypsin-EDTA (Gibco, USA) was added into the 
flasks. They were incubated at 37 °C for 10 minutes and observed under the 
microscope to ensure that the cells have completely detached from the flask surface. 
Then, 4 ml of complete growth medium was added to stop the reaction of trypsin on 
the cells. Cells were pipetted into the tube and centrifuged at 125 x g for 7 minutes. 
After the supernatant was removed, 1 ml of growth medium was added to the cell 
pellet and mixed well. Approximately 10 μl of the cell suspension was diluted with 
